Thermal Nickel-Catalyzed N -Arylation of NH-Sulfoximines with (Hetero)aryl Chlorides Enabled by PhPAd-DalPhos Ligation
Organic Letters · 23.02.2024 · 26 (7) · 1326-1331
DOI: 10.1021/acs.orglett.3c04152 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 08.02.2024. Verfasst von Samuel A Fisher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Dalhousie University, 6274 Coburg Road, Halifax, Nova Scotia B3H 4R2, Canada. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Dalhousie University, Natural Sciences and Engineering Research Council of Canada, Paraza Pharma Inc..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Chemistry, Dalhousie University, 6274 Coburg Road, Halifax, Nova Scotia B3H 4R2, Canada.
- Paraza Pharma, Inc., 2525 Avenue Marie-Curie, Montreal, Quebec H4S 2E1, Canada.
ORCID-Profile: Mark Stradiotto
Förderung
- Dalhousie University
- Natural Sciences and Engineering Research Council of Canada
- Paraza Pharma Inc.
Zitieren
APA
Fisher, S. A., Simon, C. M., Fox, P. L., Cotnam, M. J., DeRoy, P. L., & Stradiotto, M. (2024). Thermal Nickel-Catalyzed N -Arylation of NH-Sulfoximines with (Hetero)aryl Chlorides Enabled by PhPAd-DalPhos Ligation. Organic Letters, 26(7), 1326-1331. https://doi.org/10.1021/acs.orglett.3c04152
Vancouver
Fisher SA, Simon CM, Fox PL, Cotnam MJ, DeRoy PL, Stradiotto M. Thermal Nickel-Catalyzed N -Arylation of NH-Sulfoximines with (Hetero)aryl Chlorides Enabled by PhPAd-DalPhos Ligation. Organic Letters. 2024;26(7):1326-1331. doi:10.1021/acs.orglett.3c04152
BibTeX
@article{Fisher2024,
author = {Fisher, Samuel A and Simon, Connor M and Fox, Peter L and Cotnam, Michael J and DeRoy, Patrick L and Stradiotto, Mark},
title = {Thermal Nickel-Catalyzed N -Arylation of NH-Sulfoximines with (Hetero)aryl Chlorides Enabled by PhPAd-DalPhos Ligation},
journal = {Organic Letters},
year = {2024},
volume = {26},
number = {7},
pages = {1326--1331},
doi = {10.1021/acs.orglett.3c04152}
}
EUVIMED